Shuwen Liu

New York Blood Center, Chinese Academy of Sciences

Papers

2

Total Citations

75

H-Index

2

About

Dr. Shuwen Liu is a pioneering researcher at the intersection of antiviral drug discovery and advanced biomaterials, with a focus on HIV-1 therapeutics and smart responsive hydrogels. Her seminal work on developing a rapid, automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41 (2003, 50 citations) established a critical platform for identifying novel entry inhibitors, accelerating the search for antiviral agents against a key viral target. More recently, Dr. Liu has ventured into the field of intelligent materials, creating photothermally responsive and durable polydopamine-modified MXene-PNIPAM hydrogels for smart friction regulation (2024, 25 citations). This innovative work demonstrates her versatility in merging nanotechnology with stimuli-responsive polymers, offering potential applications in adaptive lubrication systems and biomedical devices. Her contributions span from foundational virology assays to cutting-edge materials engineering, reflecting a career dedicated to solving complex biomedical challenges. Dr. Liu’s research continues to inspire interdisciplinary approaches, bridging molecular biology and materials science to address pressing health and technological needs.

Research Focus

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Rapid and Automated Fluorescence-Linked Immunosorbent Assay for High-Throughput Screening of Hiv-1 Fusion Inhibitors Targeting gp41
50 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: New York Blood Center, Chinese Academy of Sciences

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago